Travere Therapeutics
(NASDAQ) TVTX
Travere Therapeutics Financials at a Glance
Market Cap
$2.47B
Revenue (TTM)
$490.73M
Net Income (TTM)
$50.26M
EPS (TTM)
$-0.60
P/E Ratio
-44.43
Dividend
$0.00
Beta (Volatility)
1.17 (Average)
Dividend
$0.00
Beta (Volatility)
1.17 (Average)
Price
$27.16
Volume
52,333.315
Open
$26.84
Price
$27.16
Volume
52,333.315
Open
$26.84
Previous Close
$26.79
Daily Range
$26.84 - $27.59
52-Week Range
$12.91 - $42.13
Dividend
$0.00
Beta (Volatility)
1.17 (Average)
Price
$27.16
Volume
52,333.315
Open
$26.84
Previous Close
$26.79
Daily Range
$26.84 - $27.59
52-Week Range
$12.91 - $42.13
TVTX News
TVTX: Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Travere Therapeutics
Industry
Biotechnology
Sector
Health CareEmployees
497
CEO
Eric M. Dube, PhD
Website
www.travere.comHeadquarters
San Diego, CA 92130, US
TVTX Financials
Key Financial Metrics (TTM)
Gross Margin
94%
Operating Margin
-13%
Net Income Margin
-10%
Return on Equity
-58%
Return on Capital
-14%
Return on Assets
-8%
Earnings Yield
-2.25%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$2.47B
Shares Outstanding
92.24M
Volume
52.33K
Short Interest
0.00%
Avg. Volume
1.97M
Financials (TTM)
Gross Profit
$419.65M
Operating Income
$62.82M
EBITDA
$22.22M
Operating Cash Flow
$37.78M
Capital Expenditure
$0.00
Free Cash Flow
$37.78M
Cash & ST Invst.
$322.80M
Total Debt
$328.73M
Travere Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$129.69M
+73.4%
Gross Profit
$109.00M
+50.9%
Gross Margin
84.05%
N/A
Market Cap
$2.47B
N/A
Market Cap/Employee
$6.42M
N/A
Employees
385
N/A
Net Income
$21.99M
+63.5%
EBITDA
$632.00K
+98.6%
Quarterly Fundamentals
Net Cash
$17.07M
+44.7%
Accounts Receivable
$81.43M
+200.3%
Inventory
$5.88M
-5.2%
Long Term Debt
$333.99M
+2.0%
Short Term Debt
$5.88M
-92.1%
Return on Assets
-8.30%
N/A
Return on Invested Capital
-14.11%
N/A
Free Cash Flow
$61.05M
+234.8%
Operating Cash Flow
$60.68M
+269.9%